Condition: Liver Transplantation · Acute Kidney Injury · Sponsor: Rennes University Hospital
To verify whether albumin administration to achieve serum concentration above 30g/L (treated group) and its maintenance within plasmatic physiologic range (above 30 g/L) for five days diminishes rate of AKI at Day 7 after liver transplantation as compared to restrained albumin administration (when serum concentration is at 20 g/L or below (control)).
This description comes directly from the study's public registry record.
Loïc JACOB · +33299282555 · loic.jacob@chu-rennes.fr
Always discuss trial participation with your own doctor first.
| 08_CHRU de Tours Hôpital Trousseau | Chambray-lès-Tours, France | Recruiting |
| 03_APHP Hôpital Beaujon | Clichy, France | Recruiting |
| 04_CHU de Lille Hôpital Huriez | Lille, France | Recruiting |
| 05_HCL Hôpital de la Croix Rousse | Lyon, France | Recruiting |
| 06_CHU de Montpellier Hôpital St Eloi | Montpellier, France | Recruiting |
| 02_CHU de Bordeaux - Hôpital Haut Leveque | Pessac, France | Recruiting |
| 01_CHU de Rennes Hôpital Pontchaillou | Rennes, France | Recruiting |
| 09_APHP Hôpital Paul Brousse | Villejuif, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06535945